Log in

Relevant bibliographies by topics / Ketoprofen/administration and dosage

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers

Academic literature on the topic 'Ketoprofen/administration and dosage'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Ketoprofen/administration and dosage.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Ketoprofen/administration and dosage"

1

Narita, Tatsuya, Reeko Sato, Nobuyuki Tomizawa, Kenji Tani, Shinobu Komori, and Shigeo Hara. "Safety of reduced-dosage ketoprofen for long-term oral administration in healthy dogs." American Journal of Veterinary Research 67, no. 7 (2006): 1115–20. http://dx.doi.org/10.2460/ajvr.67.7.1115.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Salamanca, Constain, Alvaro Barrera-Ocampo, Juan Lasso, Nathalia Camacho, and Cristhian Yarce. "Franz Diffusion Cell Approach for Pre-Formulation Characterisation of Ketoprofen Semi-Solid Dosage Forms." Pharmaceutics 10, no. 3 (2018): 148. http://dx.doi.org/10.3390/pharmaceutics10030148.

Full text

Abstract:

This study aimed to evaluate and compare, using the methodology of Franz diffusion cells, the ketoprofen (KTP) releasing profiles of two formulations: A gel and a conventional suspension. The second aim was to show that this methodology might be easily applied for the development of semi-solid prototypes and claim proof in pre-formulation stages. Drug release analysis was carried out under physiological conditions (pH: 5.6 to 7.4; ionic strength 0.15 M; at 37 °C) for 24 h. Three independent vertical Franz cells were used with a nominal volume of the acceptor compartment of 125 mL and a diffusi

APA, Harvard, Vancouver, ISO, and other styles

3

Amirdjanova, V. N., and A. Е. Karateev. "New aspects of pain management in acute and chronic inflammatory syndromes." Modern Rheumatology Journal 15, no. 1 (2021): 73–78. http://dx.doi.org/10.14412/1996-7012-2021-1-73-78.

Full text

Abstract:

Effective pain control is one of the first and most important challenges in medical practice. Non-steroidal anti-inflammatory drugs (NSAIDs) are the cornerstone of treatment for acute and chronic inflammatory pain syndromes. Of particular interest is a group of patients with a low risk of cardiovascular development and a low to moderate risk of gastrointestinal complications, for whom any NSAID may be recommended. Their choice may depend on the duration and severity of the inflammatory process. The most high analgesic potential have non-selective inhibitors of cyclooxygenase – diclofenac and k

APA, Harvard, Vancouver, ISO, and other styles

4

Hatami, Mehdi, and Khalil Farhadi. "Analysis of ketoprofen enantiomers in human and rat plasma by hollow-fiber-based liquid-phase microextraction and chiral mobile-phase additive HPLC." Canadian Journal of Chemistry 91, no. 12 (2013): 1252–57. http://dx.doi.org/10.1139/cjc-2013-0228.

Full text

Abstract:

A simple, inexpensive, and efficient preconcentration and cleanup three-phase hollow fiber liquid-phase microextraction method (HF-LPME) was developed for the extraction of the anti-inflammatory ketoprofen (KTP) from human and rat plasma and HPLC enantioseparation of its enantiomers using vancomycin as a chiral mobile-phase additive with an achiral C8 column. The effects of different parameters influencing the efficiency of extraction were optimized for aqueous samples. Under optimized conditions, KTP enantiomers were extracted from 0.5 mL of plasma diluted to 5 mL with salinated and acidified

APA, Harvard, Vancouver, ISO, and other styles

5

KOBAYASHI, Minae, Shigeki MATSUKT, Shigenori ARAI, Hisao SHIBATA, and Hiroaki KUBO. "Metabolism of ketoprofen following single rectal dosage in elderly subjects." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 21, no. 4 (1990): 675–81. http://dx.doi.org/10.3999/jscpt.21.675.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Shohin, Igor E., Julia I. Kulinich, Galina V. Ramenskaya, et al. "Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Ketoprofen." Journal of Pharmaceutical Sciences 101, no. 10 (2012): 3593–603. http://dx.doi.org/10.1002/jps.23233.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Souza, C. M., P. A. Auler, D. C. Reis, G. E. Lavalle, E. Ferreira, and G. D. Cassali. "Subcutaneous administration of ketoprofen delays Ehrlich solid tumor growth in mice." Arquivo Brasileiro de Medicina Veterinária e Zootecnia 66, no. 5 (2014): 1376–82. http://dx.doi.org/10.1590/1678-6729.

Full text

Abstract:

Ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID) has proven to exert anti-inflammatory, anti-proliferative and anti-angiogenic activities in both neoplastic and non-neoplastic conditions. We investigated the effects of this compound on tumor development in Swiss mice previously inoculated with Ehrlich tumor cells. To carry out this study the solid tumor was obtained from cells of the ascites fluid of Ehrlich tumor re-suspended in physiological saline to give 2.5x106cells in 0.05mL. After tumor inoculation, the animals were separated into two groups (n = 10). The animals treated with k

APA, Harvard, Vancouver, ISO, and other styles

8

CORVELEYN, S., P. DEPREZ, G. VAN DER WEKEN, W. BAEYENS, and J. P. REMON. "Bioavailability of ketoprofen in horses after rectal administration." Journal of Veterinary Pharmacology and Therapeutics 19, no. 5 (1996): 359–63. http://dx.doi.org/10.1111/j.1365-2885.1996.tb00064.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hsu, Li-Ren, Yaw-Bin Huang, Pao-Chu Wu, and Yi-Hung Tsai. "Effects of the Administration of Ketoprofen gel on the Percutaneous Absorption of Ketoprofen in Rabbits." Drug Development and Industrial Pharmacy 20, no. 6 (1994): 1093–101. http://dx.doi.org/10.3109/03639049409038354.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

AlKatheeri, N., and I. Lambert. "Pharmacokinetics of R- and S-ketoprofen after multiple intravenous administration of ketoprofen racemate in camels." Emirates Journal of Food and Agriculture 13, no. 1 (2001): 66. http://dx.doi.org/10.9755/ejfa.v13i1.5233.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Ketoprofen/administration and dosage"

1

Arantes, Viviana Moraes Neder. "Analgesia preemptiva do cetoprofeno e do parecoxibe em cirurgia para remoção de terceiros molares inclusos." Universidade de São Paulo, 2006. http://www.teses.usp.br/teses/disponiveis/5/5152/tde-29012007-153432/.

Full text

Abstract:

Este trabalho prospectivo, duplo-cego randomizado, avaliou o efeito da analgesia preemptiva do cetoprofeno e do parecoxibe. Sessenta pacientes foram submetidos à cirurgia para remoção de terceiros molares inferiores bilaterais inclusos, sendo operado um lado de cada vez. O paciente foi seu próprio controle. Os pacientes foram separados em dois grupos de 30 pacientes. No grupo parecoxibe, na primeira operação foi usado o parecoxibe ou placebo, endovenoso, 30 minutos antes da cirurgia e imediatamente após a operação foi feita a administração do placebo ou parecoxibe, garantindo ao paciente receb

APA, Harvard, Vancouver, ISO, and other styles

2

Wakelkamp, Monique. "Furosemide dosage input - consequences for diuretic effect, tolerance and efficiency /." Stockholm, 1997. http://diss.kib.ki.se/1997/91-628-2612-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Börjeson, Sussanne. "Nausea and emesis in cancer chemotherapy : aspects of occurrence, assessment and treatment /." Stockholm, 1998. http://diss.kib.ki.se/search/diss.se.cfm?19980512borj.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kapraali, Marjo. "Prostaglandin E₂ influences the gastrointestinal endocrine cell system in the rat /." Stockholm, 1998. http://diss.kib.ki.se/search/diss.se.cfm?19980918kapr.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Persson, Jan. "Low dose ketamine : analgesia and side-effects in patients and volunteers /." Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3641-2/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Eriksson, Björn E. "Angina pectoris: neurophysiological mechanisms : with special references to adenosine and Syndrome X /." Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3809-1/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Muschert, Susanne. "Polymeric coatings for solid dosage forms : characterization and optimization." Lille 2, 2008. http://www.theses.fr/2008LIL2S023.

Full text

Abstract:

Les dispersions aqueuses de polymère sont couramment utilisées dans l'industrie pharmaceutique pour pelliculer les formes galéniques destinées à la voie orale et permettre une libération contrôlée du principe actif. Il est nécessaire de faire attention à la stabilité à long terme des films au cours du stockage et d'éviter une diminution des taux de principe actif libéré par continuation de la coalescence des particules de polymère. L'idée de ce travail était d'ajouter un second composant approprié aux dispersions aqueuses d'éthyle cellulose afin d'améliorer la formation du film et la stabilité

APA, Harvard, Vancouver, ISO, and other styles

8

Eriksson-Mjöberg, Marianne. "Intravenous morphine after gynecological surgery : pain relief, endocrine and immune response /." Stockholm, 1997. http://diss.kib.ki.se/1997/19971107erik.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Lindmarker, Per. "Treatment of deep vein thrombosis and risk of recurrent venous thromboembolism /." Stockholm, 1998. http://diss.kib.ki.se/1998/91-628-3211-5/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Brzezinska, Selldén Eva. "Amino acid-induced thermogenesis during anaesthesia /." Stockholm, 1998. http://diss.kib.ki.se/1998/91-628-3212-3/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Ketoprofen/administration and dosage"

1

Dosage calculations. 7th ed. Thomson/Delmar Learning, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Erickson, Belle. Dosage calculations. 2nd ed. Springhouse Corporation, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Sylvie, Dubois, ed. Calcul, dosage, médicaments. 2nd ed. Chenelière/McGraw-Hill, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Olsen, June Looby. Dosage calculations. Springhouse Corp., 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Todd, Catherine M. Dosage calculations manual. 2nd ed. Springhouse, Corp., 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

L, Mull Valerie, ed. Dosage calculations manual. Springhouse Pub. Co., 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Belle, Erickson, ed. Dosage calculations manual. 3rd ed. Springhouse Corp., 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Introduction to pharmaceutical dosage forms. 4th ed. Lea & Febiger, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hegstad, Lorrie N. Essential drug dosage calculations. 2nd ed. Appleton & Lange, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hegstad, Lorrie N. Essential drug dosage calculations. 3rd ed. Appleton & Lange, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Ketoprofen/administration and dosage"

1

Schneeweiss, Adam, and Marija Weiss. "Dosage and Administration." In Advances in Nitrate Therapy. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-97066-5_27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Schneeweiss, Adam, and Marija Weiss. "Dosage and Administration." In Advances in Nitrate Therapy. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-75834-8_27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hacısalihzade, Selim S. "Drug Administration and Dosage Optimization." In Lecture Notes in Control and Information Sciences. Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-37279-7_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Tullner, W. W., J. P. Young, and R. Hertz. "Administration of Massive Dosage of Oestrogen to Breast and Prostatic Cancer Patients; Blood Levels Attained." In Ciba Foundation Symposium - Steroid Hormones and Tumour Growth (Book I of Colloquia on Endocrinology, Vol. 1). John Wiley & Sons, Ltd., 2008. http://dx.doi.org/10.1002/9780470718759.ch13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Kane, J. M. "Dosage and Route of Administration of Neuroleptic Drugs During Different Phases of a Schizophrenic Illness." In Guidelines for Neuroleptic Relapse Prevention in Schizophrenia. Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-86922-8_16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Bhattacharjee, Himanshu, and Laura Thoma. "Parenteral drug administration." In Pharmaceutical Dosage Forms - Parenteral Medications. CRC Press, 2012. http://dx.doi.org/10.3109/9781420086447-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

"Dosage and routes of administration." In Therapeutic uses of cannabis. CRC Press, 2020. http://dx.doi.org/10.1201/9781003078418-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sultatos, Lester. "Dosage Regimens for Drug Administration." In xPharm: The Comprehensive Pharmacology Reference. Elsevier, 2007. http://dx.doi.org/10.1016/b978-008055232-3.60071-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

"Routes of administration, pharmacokinetics, dosage." In Immune Interferon. CRC Press, 2001. http://dx.doi.org/10.1201/9781420040739.ch8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

"Routes of administration, pharmacokinetics, dosage." In Immune Interferon. CRC Press, 2001. http://dx.doi.org/10.1201/9781420040739-13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Ketoprofen/administration and dosage"

1

DAMAS, J., V. GREGG, and G. REMACLE-VOLON. "INHIBITION OF THE THROMBOPENIC EFFECT OF ELLAGIC ACID BY PCR 4099, AN ANTIAGGRGATING AGENT, IN RATS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643449.

Full text

Abstract:

In the rat, intravenous injection of large doses (30 mg/Kg) of ellagic acid (EA) induced a decrease in the plasma level of fibrinogen and in the blood platelet content and an increase of the activated partial thromboplastin time. EA induced the accumulation of Crs1-labelled platelets into the lung and the liver accompanied by a 64% fall in Cr51 blood radioactivity.The long-lasting thrombocytopenia induced by EA was inhibited by heparin (4 mg/Kg), defibrase (20 U/Kg), and clocoumarol (4 mg/Kg). It was not inhibited by aspirin (90 mg/Kg), indomethacin (8 mg/Kg) and ketoprofen (4-10 mg/Kg). The t

APA, Harvard, Vancouver, ISO, and other styles

2

"Intelligent Drug/Dosage Decision & Administration Using R-Pi SBC An Intravenous Pre-Operative Insulin Administration Scenario." In Dec. 14-16, 2016 Pattaya. Dignified Researchers Publication, 2016. http://dx.doi.org/10.15242/dirpub.dir1216015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Eesmaa, L., ÜH Meren, K. Luik, and K. Sirkas. "INT-007 Administration of solid dosage forms to patients with dysphagia or via feeding tubes." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.388.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Fenichel, R. L., W. Carmint, B. Small, and J. Willis. "COMPARISON OF THE ANTITHROMBOTIC, ANTICLOTTING AND ANTIPLATELET AGGREGATORY ACTIVITIES OFLOW MOLECULAR WEIGHT RD HEPARIN WITH HEPARIN." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644854.

Full text

Abstract:

An initial comparison of in vitro plasma anti-factor Xa (anti Xa) and activated partial thromboplastin time (APTT) values of RD heparin with heparin based upon USP units shows increased anti Xa and decreased APTT activity of RD heparin. An ex vivo experiment in rabbits in which 100 USP units/kg of RD heparinand 200 USP units/kg of heparin, when given by the subcutaneous route, reflects the significantly increased anti Xa activity generated by RD heparin as wellas its longer duration of action. No significant difference in APTT activity was observed for the two heparins, but an increased anti X

APA, Harvard, Vancouver, ISO, and other styles

5

Poppv, S., A. Philapitsch, H. Murday, J. Fenyes, and P. G. Kirchhoff. "CONTINUOUS PERIOPERATIVE ADMINISTRATION OF Cl-ESTERASE-INHIBITOR CONCENTRATE AND APROTININ IN CARDIOVASCULAR SURGERY." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644328.

Full text

Abstract:

The results obtained in our randomised study in 3 groups of patients performed in 1982/83 suggested the administration of protease inhibitors to be effective in counteracting the activation of the kallikrein, coagulation and fibrinolytic systems during extracorporeal circulation (ECC) thus lowering the rate of postoperative bleeding complications. Since Cl-esterase-inhibitor (Cl-INH) proved to be the main inhibitor of the kallikrein (KK) system and aprotinin that of plasmin further studies to investigate the efficacy of a combined treatment and to develop an improved dosage regimen were initia

APA, Harvard, Vancouver, ISO, and other styles

6

Giassi, Karina, Renato Gorga Bandeira de Mello, Bruna Cambrussi de Lima, Gabriela Stahl, Raquel Almeida de Oliveira, and Marina Siqueira Flores. "RANDOMIZED CONTROLLED TRIAL COMPARING MORNING VERSUS NIGHT ADMINISTRATION OF LEVOTHYROXINE IN OLDER PERSONS." In XXII Congresso Brasileiro de Geriatria e Gerontologia. Zeppelini Publishers, 2021. http://dx.doi.org/10.5327/z2447-21232021res04.

Full text

Abstract:

OBJECTIVE: To evaluate the effectiveness of levothyroxine administration strategies in the treatment of hypothyroidism in older persons in a tertiary outpatient clinic. METHODS: A randomized controlled trial of older persons with a diagnosis of primary hypothyroidism who had been receiving levothyroxine for at least 6 months with a stable dose in the last 3 months. Patients were randomly assigned to one of two administration strategies: morning (1 hour before breakfast) or night (1 hour after the last meal). In a period ≥ 12 weeks, patients were instructed to cross over between strategies. Lab

APA, Harvard, Vancouver, ISO, and other styles

7

Lloyd, J. V., S. E. Rodgers, D. M. Siebert, F. Bochner, G. H. McIntosh, and M. James. "PRESYSTEMIC DEACETYLATION OF LOW DOSES OF ENTERIC COATED ASPIRIN IN A PIG MODEL." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643856.

Full text

Abstract:

The antithrombotic effect of aspirin might be enhanced if platelet cyclooxygenase could be inhibited in the portal ciculation while sparing cyclooxygenase in the systemic vascular endothelium. This might be achieved by modifying the dose and formulation to maximise presystemic aspirin clearance by the liver. To test this hypothesis low dose enteric coated aspirin (Astrix, 50mg single dose, lOOmg single dose and lOOmg daily for 1 week) was orally administered to pigs with permanent indwelling arterial and portal vein catheters. Plasma aspirin concentrations were measured by high performance liq

APA, Harvard, Vancouver, ISO, and other styles

8

Arnesen, K. E., G. F. Handeland, U. Abildgaard, P. Gottschalk, G. Stene-Larsen, and D. W. T. Nilsen. "WHAT IS THE OPTIMAL DOSAGE OF LMW HEPARIN IN THE SC TREATMENT OF DEEP VENOUS THROMBOSIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643593.

Full text

Abstract:

LMW heparin (LMWH) is better suited for subcutaneous (sc) administration than is UF heparin due to higher bioavailability and slower elimination. Optimal dosage for sc treatment of DVT has not been defined. Our previous study suggested that LMWH should be given in doses according to bodyweight (bw), and that sc injection of 100 anti-Xa U/kg bw/12 hrs might result in therapeutic plasma levels (Holm et al. Haemostasis 16, supl 2,30-37, 1986). This dosage is now being evaluated in an open study including patients with venographically proven DVT. Excluded were patients with pulmonary embolism, thr

APA, Harvard, Vancouver, ISO, and other styles

9

Park, Juyoung, Peter M. Bungay, Robert J. Lutz, et al. "Comparison of Convective Transport of Drug Between Intravitreal Injection and Controlled Release Implant." In ASME 2004 International Mechanical Engineering Congress and Exposition. ASMEDC, 2004. http://dx.doi.org/10.1115/imece2004-59300.

Full text

Abstract:

It is important to know the drug distribution following administration of drug in order to properly treat with adequate dosage and thus, avoid damage to tissues due to excessive high concentrations. A computer model was developed to determine drug distribution by convective-diffusive transport processes in a rabbit eye. When compared with pure diffusion within vitreous, the ratio of the amount of a model compound, fluorescein, reaching the retina to that cleared by aqueous outflow increased by 93% and 84% for intravitreal injection and implant, respectively, with maximum vitreous outflow (glau

APA, Harvard, Vancouver, ISO, and other styles

10

Semenov, Sergey, Alexandr Bozhchenko, and Pavel Tolkach. "Iatrogenic death of a patient as a result of local anesthesia with the use of the drug “Naropin”." In Issues of determining the severity of harm caused to human health as a result of the impact of a biological factor. Publishing Center RIOR, 2020. http://dx.doi.org/10.29039/conferencearticle_5fdcb03ab42468.53224529.

Full text

Abstract:

The article considers the clinical and forensic aspects of the possibility of establishing a causal relationship between the use of the drug “Naropin” and the death of a patient during local anesthesia. In this case, the patient sought outpatient medical care for paraproctitis. The decision made by the doctor the decision for local anesthesia is the use of the drug “Naropin”. At 20 minutes of administration of the drug in the required dosage, the patient suddenly developed convulsions and clinical death occurred, and later the patient died. When conducting a forensic examination of the corpse,

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!